A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.
Robbins
J B
JB
National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. robbinsjo@mail.nih.gov
Schneerson
R
R
Gotschlich
E C
EC
D000328:Adult; D017954:Africa South of the Sahara / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control*; D019353:Endemic Diseases / Q000517:prevention & control*; D006801:Humans; D017589:Immunization Programs; D007223:Infant; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000008:administration & dosage / Q000276:immunology; D014611:Vaccination; D014944:World Health Organization
D022401:Meningococcal Vaccines